QS Investors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$201K Sell
2,058
-300
-13% -$29.3K ﹤0.01% 1066
2021
Q1
$230K Hold
2,358
﹤0.01% 1069
2020
Q4
$226K Buy
2,358
+257
+12% +$24.6K ﹤0.01% 1080
2020
Q3
$203K Hold
2,101
﹤0.01% 1071
2020
Q2
$257K Sell
2,101
-425
-17% -$52K ﹤0.01% 1077
2020
Q1
$219K Buy
2,526
+185
+8% +$16K ﹤0.01% 1040
2019
Q4
$254K Sell
2,341
-240
-9% -$26K ﹤0.01% 1135
2019
Q3
$233K Buy
2,581
+240
+10% +$21.7K ﹤0.01% 1167
2019
Q2
$198K Hold
2,341
﹤0.01% 1222
2019
Q1
$207K Sell
2,341
-9
-0.4% -$796 ﹤0.01% 1210
2018
Q4
$168K Hold
2,350
﹤0.01% 1183
2018
Q3
$289K Hold
2,350
﹤0.01% 1102
2018
Q2
$231K Hold
2,350
﹤0.01% 1165
2018
Q1
$195K Hold
2,350
﹤0.01% 1184
2017
Q4
$182K Buy
2,350
+341
+17% +$26.4K ﹤0.01% 1244
2017
Q3
$123K Hold
2,009
﹤0.01% 1377
2017
Q2
$92K Hold
2,009
﹤0.01% 1399
2017
Q1
$87K Buy
2,009
+2,000
+22,222% +$86.6K ﹤0.01% 1412
2016
Q4
$1K Hold
9
﹤0.01% 1674
2016
Q3
$1K Hold
9
﹤0.01% 1664
2016
Q2
$1K Sell
9
-136,502
-100% -$15.2M ﹤0.01% 1707
2016
Q1
$5.4M Hold
136,511
0.05% 358
2015
Q4
$7.72M Buy
136,511
+10,359
+8% +$586K 0.07% 244
2015
Q3
$5.02M Sell
126,152
-200
-0.2% -$7.96K 0.05% 357
2015
Q2
$6.04M Hold
126,352
0.07% 321
2015
Q1
$5.02M Hold
126,352
0.06% 376
2014
Q4
$2.82M Buy
+126,352
New +$2.82M 0.03% 510